Narrow search
Showing 1 - 10 of 613
Cover Image
Cutting too close? : design protection and innovation in fashion goods
Hackett, Petal Jean - 2012
Continued lobbying by high-end, American designers for intellectual property-type fashion design protection has culminated in the proposed Innovative Design Protection and Piracy Prevention Act, intended to introduce EU standards. Using a sequential, 2-firm, vertical differentiation framework,...
Persistent link: https://www.econbiz.de/10009488919
Cover Image
Does reference pricing drive out generic competition in pharmaceutical markets? : evidence from a policy reform
Brekke, Kurt R.; Canta, Chiara; Straume, Odd Rune - 2022
Policy makers use reference pricing to curb pharmaceutical expenditures by reducing coverage of expensive branded drugs. In a theoretical analysis we show that the net effect of reference pricing is generally ambiguous when accounting for entry by generic producers. Reference pricing shifts...
Persistent link: https://www.econbiz.de/10013285854
Cover Image
Longitudinal analysis of generic substitution
Dalen, Dag Morten; Locatelli Biey, Marilena; Strøm, Steinar - 2010
Using an extensive longitudinal dataset extracted from the Norwegian Prescription Database (NorPD) containing all prescriptions written in the period January 2004 to June 2007, we selected two particular drugs (chemical substances) used against cholesterol. The two brand-name products on the...
Persistent link: https://www.econbiz.de/10008697144
Cover Image
Reference pricing of pharmaceuticals
Brekke, Kurt R. (contributor);  … - 2006
Persistent link: https://www.econbiz.de/10003379831
Cover Image
Margins and market shares : pharmacy incentives for generic substitution
Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - 2012
generics and their market shares. This relationship is stronger for pharmaceuticals under reference pricing rather than …. -- pharmaceuticals ; pharmacies ; generic substitution …
Persistent link: https://www.econbiz.de/10009691207
Cover Image
Reference pricing, competition, and pharmaceutical expenditures : theory and evidence from a natural experiment
Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - 2010
-sample of off-patent products. First, we construct a vertical differentiation model to analyze the impact of regulation on … several off-patent molecules before and after the policy reform. Off-patent drugs not subject to RP serve as our control group …-savings, and that patients' copayments decrease despite the extra surcharges under RP. -- pharmaceuticals ; regulation ; generic …
Persistent link: https://www.econbiz.de/10008749029
Cover Image
Tax competition, relative performance and policy imitation
Wagener, Andreas - 2009
Rather than about absolute payoffs, governments in fiscal competition often seem to care about their performance relative to other governments. Moreover, they often appear to mimic policies observed elsewhere. We study such behaviour in a tax competition game with mobile capital à la...
Persistent link: https://www.econbiz.de/10003871945
Cover Image
Labor unions, globalization, and mercantilism
Grieben, Wolf-Heimo; Sener, Fuat - 2009
Northern trade liberalization reduces the rate of innovation, increases Northern unemployment, and reduces both Northern and …
Persistent link: https://www.econbiz.de/10003923503
Cover Image
Mind the knowledge gap! : the origins of declining business dynamism in a macro agent-based model
Delli Gatti, Domenico; Terranova, Roberta; Turco, Enrico - 2023
inverse U-shaped relationship between patent strength and growth: moderate levels of patent protection can stimulate growth …
Persistent link: https://www.econbiz.de/10014383652
Cover Image
The effect of intellectual property rights on domestic innovation in the pharmaceutical sector
Gamba, Simona - 2016
. Domestic innovation is measured as citation-weighted domestic patents filed at the European Patent Office (EPO): to account for … to patent at the EPO. Results show that, in the short-run, IPR stimulate innovation. The effect for developing countries …This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of …
Persistent link: https://www.econbiz.de/10011509446